Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of First-Time acute myocardial infarction☆
References (15)
A database worth saving
Lancet
(1997)- et al.
Acute respiratory tract infections and risk of first-time acute myocardial infarction
Lancet
(1998) Atherosclerosis—an inflammatory disease
N Engl J Med
(1999)- et al.
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
Circulation
(2003) - et al.
Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden
J Rheumatol
(1997) - et al.
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
Arthritis Rheum
(2001) - et al.
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosuscomparison with the Framingham Study
Am J Epidemiol
(1997)
There are more references available in the full text version of this article.
Cited by (198)
CardioRheumatology
2021, Sex Differences in Cardiac Diseases: Pathophysiology, Presentation, Diagnosis and ManagementAutoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry
2020, American Journal of MedicineAssociation of acute myocardial infarction with seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study
2020, Journal of Clinical NeurosciencePrediction of Major Adverse Cardiovascular Events by Triglyceride Glucose Index in Predominantly Male Patients with Rheumatoid Arthritis
2024, Reviews in Cardiovascular MedicineComorbidities among Egyptian systemic lupus erythematosus: The COMOSLE-EGYPT study
2023, Chronic Illness
- ☆
The Boston Collaborative Drug Surveillance Program was partly supported by grants from Hoffmann-La Roche, Basel, Switzerland. This study was not directly funded. Dr. Meier was supported by a grant from the Swiss National Science Foundation (grant No 32-67808.02), Basel, Switzerland. Dr. Matter was supported by the EU grant G5RD-CT-2001-00532, Brussels, Belgium; and by grant 02.0057 from the Bundesamt für Bildung und Wissenschaft, Bern, Switzerland.
Copyright © 2004 Excerpta Medica Inc. All rights reserved.